$GLAXF

GLAXOSMITHKLINE PLC

CIK:0001131399|SEC Filings
v3.25.4
Consolidated income statement - GBP (£)
£ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Profit or loss [abstract]      
Turnover £ 32,667 £ 31,376 £ 30,328
Cost of sales (9,017) (9,048) (8,565)
Gross profit 23,650 22,328 21,763
Selling, general and administration (9,088) (11,015) (9,385)
Research and development (7,525) (6,401) (6,223)
Royalty income 879 639 953
Other operating income/(expense) 16 (1,530) (363)
Operating profit 7,932 4,021 6,745
Finance income 169 122 115
Finance expense (701) (669) (792)
Share of after tax profit/(loss) of associates and joint ventures 1 (3) (5)
Profit/(loss) on disposal of interests in associates and joint ventures 0 6 1
Profit before taxation 7,401 3,477 6,064
Taxation (1,112) (526) (756)
Profit after taxation 6,289 2,951 5,308
Profit attributable to non-controlling interests 573 376 380
Profit attributable to shareholders £ 5,716 £ 2,575 £ 4,928
Basic earnings per share (pence) (in pence per share) £ 1.411 £ 0.632 £ 1.216
Diluted earnings per share (pence) (in pence per share) £ 1.388 £ 0.622 £ 1.199